This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Ulrike Pfaar: Innovator in Pharmaceutical Chemistry
Introduction
Ulrike Pfaar is a notable inventor based in Rheinfelden, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on N-phenyl-2-pyrimidine-amine derivatives.
Latest Patents
Ulrike holds 1 patent for her invention titled "N-oxides of N-phenyl-2-pyrimidine-amine derivatives." This invention relates to N-phenyl-2-pyrimidine-amine derivatives in which at least one nitrogen atom carries an oxygen atom to form the corresponding N-oxides. The patent also covers processes for the preparation of these compounds, pharmaceutical compositions that include them, and their use in therapeutic treatments for warm-blooded animals, including humans.
Career Highlights
Throughout her career, Ulrike has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. Her work has been instrumental in advancing the development of new therapeutic agents.
Collaborations
Ulrike has collaborated with esteemed colleagues such as Klaus Olaf Börnsen and Peter End, contributing to a rich exchange of ideas and innovations in her field.
Conclusion
Ulrike Pfaar's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in the development of new medical treatments. Her work continues to influence the industry and improve therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile